Antinori, Andrea
Cossu, Maria V.
Menzaghi, Barbara
Sterrantino, Gaetana
Squillace, Nicola
Di Cristo, Valentina
Cattelan, Annamaria
Focà, Emanuele
Castagna, Antonella
Orofino, Giancarlo
Valenti, Daniela
D’Ettore, Gabriella
Aprea, Lucia
Ferrara, Sergio
Locatelli, Maria E.
Madeddu, Giordano
Pontali, Emanuele
Scerbo, Paolo
Rossetti, Barbara
Uglietti, Alessia
Termini, Roberta
Rucci, Francesco
Gori, Andrea
Mancusi, Daniela
Funding for this research was provided by:
Jansenn Cilag Italy
Article History
First Online: 8 April 2020
Change Date: 29 May 2020
Change Type: Correction
Change Details: In the original version of this article, in Fig.��2b the formatting on the x-axis of the graph has been published incorrectly.
Compliance with Ethical Standards
:
: This study was funded by Janssen-Cilag SpA.
: Andrea Antinori received a grant from Gilead Sciences, ViiV Healthcare, and Janssen-Cilag; he received consulting fees or honorarium from ViiV Healthcare, Janssen-Cilag, and Merck. Emanuele Foca has received consultancy fees and honoraria by several pharmaceutical companies in the field of HIV infections. Annamaria Cattelan received a grant from Janssen-Cilag and consulting fees or honorarium from ViiV Healthcare, MSD, Gilead Sciences, and Janssen-Cilag. Giordano Madeddu received consulting fees or honorarium from ViiV Healthcare, Gilead Sciences, MSD, and Janssen-Cilag; he received a speaker’s fee from ViiV Healthcare, Angelini, and Pfizer. Emanuele Pontali received consulting fees or honorarium for advisory board participation for Janssen-Cilag; he received payments for training activities for Janssen-Cilag. Barbara Rossetti received consulting fees or honorarium for educational activities with REPs and a support for meeting participation. Andrea Gori received a grant from Janssen-Cilag, ViiV Healthcare, MSD, BMS, Abbvie, Gilead Sciences, Novartis, Pfizer, Astellas, AstraZeneca, and Angelini; he received consulting fees or honorarium from Janssen-Cilag, ViiV Healthcare, MSD, BMS, Abbvie, Gilead Sciences, Novartis, Pfizer, Astellas, AstraZeneca, and Angelini. Maria V. Cossu, Barbara Menzaghi, Gaetana Sterrantino, Nicola Squillace, Valentina Di Cristo, Antonella Catagna, Giancarlo Orofino, Daniela Valenti, Gabriella D’Ettore, Lucia Aprea, Sergio Ferrara, Maria E. Locatelli, Paolo Scerbo, and Francesco Rucci have no conflicts of interest that are directly relevant to the content of this article. Alessia Uglietti, Roberta Termini, and Daniela Mancusi are Janssen employees.